Forteo (teriparatide) works by mimicking a natural hormone in your body to actively build new bone, rather than simply slowing bone loss like most osteoporosis drugs. It’s a synthetic version of the first 34 amino acids of parathyroid hormone (PTH), the hormone your body already uses to regulate calcium and bone metabolism. Given as a daily injection for up to two years, Forteo reduced the risk of new spinal fractures by 65% and non-spinal fractures by 53% in its landmark clinical trial.
Why Forteo Is Different From Other Osteoporosis Drugs
Most osteoporosis medications are “antiresorptive,” meaning they work by slowing the natural breakdown of old bone. Forteo takes the opposite approach. It’s an anabolic drug, meaning it stimulates your body to form new bone tissue. This distinction matters because antiresorptive drugs preserve what you have, while Forteo adds to it. That makes it a particularly valuable option for people with severe osteoporosis or those who have already fractured despite being on other treatments.
How It Builds New Bone
Forteo binds to receptors found on the surface of osteoblasts, the cells responsible for building bone. Once it locks onto these receptors, it triggers a chain of signals inside the cell that ultimately ramps up bone production through three key pathways.
First, it increases the production of growth factors that encourage new osteoblasts to form. Second, it dials down sclerostin, a protein that normally acts as a brake on bone building. With that brake released, a major bone-growth signaling pathway (called Wnt) becomes more active. Third, it boosts the activity of a protein that drives immature cells to become fully functioning osteoblasts.
The net result: more bone-building cells survive longer and produce more bone tissue. This leads to new growth in both the spongy interior of bones (trabecular bone) and the dense outer shell (cortical bone), which together improve bone strength and density.
Why the Timing of Each Dose Matters
Here’s the key insight behind Forteo’s design. Parathyroid hormone can either build bone or break it down, depending on how the body is exposed to it. Continuous, elevated PTH (as seen in hyperparathyroidism) actually pulls calcium out of bones and weakens them. But brief, intermittent pulses of PTH stimulate bone formation. Forteo exploits this by delivering a single small dose once a day, creating that short pulse that tips the balance toward building rather than breaking down bone.
What Treatment Looks Like Day to Day
Forteo is injected once daily at a dose of 20 micrograms, using a prefilled disposable pen. You inject it just under the skin, either in your thigh or your abdominal wall. Each pen contains enough medication for 28 days of use. Before your first injection from a new pen, you’ll need to prime it by following a short sequence of turning and pulling the dose knob, then pressing the injection button to clear any air. After that, setting the daily dose is straightforward.
The pen needs to stay refrigerated between 36°F and 46°F (2°C to 8°C) at all times. It should never be frozen, and if it has been frozen, it must be discarded. After 28 days, you throw the pen away even if medication remains inside. The liquid itself should look clear and colorless with no particles floating in it.
How Long You Can Take It
Forteo treatment is typically limited to two years. Current FDA labeling states that use beyond two years during a patient’s lifetime should only be considered if you remain at high risk for fracture or have returned to that level of risk. This limit exists partly because there is limited safety data beyond that window. In animal studies, rats given teriparatide developed osteosarcoma, a type of bone cancer. However, the FDA removed its boxed warning about this risk in late 2020 after long-term observational studies in humans found no increased risk of osteosarcoma in adults treated with the drug.
What Happens After You Stop
One of the most important things to understand about Forteo is that stopping it without a follow-up plan can undo much of its benefit. The bone density gains from Forteo wear off relatively quickly after you stop injecting. Significant bone loss has been documented in patients who simply discontinue treatment without transitioning to another medication.
This is why doctors almost always prescribe an antiresorptive drug after a course of Forteo. The idea is sequential therapy: Forteo builds new bone over one to two years, and then an antiresorptive medication locks those gains in place by slowing bone breakdown. Skipping this second step is one of the most common ways patients lose the benefit of treatment.
Fracture Reduction Results
The Fracture Prevention Trial, a large randomized study of over 1,600 postmenopausal women with osteoporosis, established Forteo’s effectiveness. Women who received the 20-microgram daily dose saw a 65% reduction in new vertebral (spinal) fractures compared to placebo. For moderate or severe vertebral fractures, the reduction was 90%. The risk of non-spinal fragility fractures dropped by 53%. These are among the strongest fracture-reduction numbers of any osteoporosis treatment, which is why Forteo is often reserved for patients at highest risk.
Common Side Effects
The most frequently reported side effects include dizziness, leg cramps, nausea, and joint pain. Some people experience a brief drop in blood pressure after injecting, which can cause lightheadedness. This is more likely during the first several doses. Sitting or lying down for the injection and for a few minutes afterward can help. Mild increases in blood calcium levels can also occur, though they’re usually temporary and don’t cause noticeable symptoms. Injection-site redness or irritation is possible but tends to be minor.